Key Insights

Highlights

Success Rate

97% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.8%

1 terminated out of 120 trials

Success Rate

97.3%

+10.8% vs benchmark

Late-Stage Pipeline

17%

20 trials in Phase 3/4

Results Transparency

14%

5 of 36 completed with results

Key Signals

5 with results97% success

Data Visualizations

Phase Distribution

81Total
Not Applicable (44)
Early P 1 (1)
P 1 (6)
P 2 (10)
P 3 (6)
P 4 (14)

Trial Status

Completed36
Recruiting31
Unknown19
Active Not Recruiting18
Not Yet Recruiting12
Withdrawn2

Trial Success Rate

97.3%

Benchmark: 86.5%

Based on 36 completed trials

Clinical Trials (120)

Showing 20 of 20 trials
NCT04235257Phase 4Active Not RecruitingPrimary

Intradermal, Fractional Dose of HPV Vaccines:

NCT05291871Phase 4Active Not RecruitingPrimary

Immunogenicity of Fractional Dose of the HPV Vaccines

NCT04206813Phase 4Active Not RecruitingPrimary

An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen

NCT07545746Phase 2Not Yet Recruiting

Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya

NCT07428330Not ApplicableRecruiting

Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV

NCT07453459Not ApplicableRecruiting

Feasibility of HPV Self-Collection Kits for Cervical Cancer Screening

NCT06210854Phase 2Not Yet RecruitingPrimary

Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+

NCT05935644Not ApplicableEnrolling By Invitation

ORCHID: An Online Intervention for Persons With HIV (Miami)

NCT07225530Not ApplicableRecruiting

Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR)

NCT05883111Not ApplicableActive Not RecruitingPrimary

HPV Self-testing in Transgender Individuals

NCT07281599Not ApplicableRecruitingPrimary

Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer

NCT06752083CompletedPrimary

Efficacy of Lentinula Edodes-Derived Supplement (AHCC®) in Promoting Negativity of Persistent HPV Infection

NCT06291311RecruitingPrimary

Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants

NCT04255849Phase 3Active Not Recruiting

Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV

NCT05524025CompletedPrimary

The SPOT-HPV Study

NCT05262010Phase 3RecruitingPrimary

A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years

NCT07344337Not ApplicableNot Yet RecruitingPrimary

Evaluation of the Effect of a Dietary Supplement Based on EGCG, Vitamin B12, Hyaluronic Acid, and Folic Acid on the Maintenance of Physiological Balance and the Natural Defenses of the Male Genital System in Subjects Exposed to HPV Infection.

NCT06302725Not ApplicableActive Not RecruitingPrimary

Vaginal Self-sampling for Detecting High-risk Human Papillomavirus Cervical Infection in Patients With Immune-mediated Inflammatory Diseases

NCT07336134Not ApplicableRecruiting

PopSci CHW4CervixHealth

NCT06458062Not ApplicableRecruiting

Pocket Colposcopy Using CARE Algorithm

Scroll to load more

Research Network

Activity Timeline